Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Srgnem1/Cya
Common Name:
Srgn-KO
Product ID:
S-KO-03772
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Srgn-KO
Strain ID
KOCMP-19073-Srgn-B6N-VA
Gene Name
Srgn
Product ID
S-KO-03772
Gene Alias
Prg; Prg1; Sgc
Background
C57BL/6NCya
NCBI ID
19073
Modification
Conventional knockout
Chromosome
10
Phenotype
MGI:97756
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Srgnem1/Cya mice (Catalog S-KO-03772) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000020271
NCBI RefSeq
NM_011157
Target Region
Exon 2
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Srgn, also known as serglycin, is a proteoglycan gene expressed in immune cells. It is involved in multiple biological processes and associated with various disease-related pathways. For example, it may be involved in cell-cell interactions, inflammation, and tumor-related processes [1-10]. Gene knockout (KO) models have been valuable in studying its function.

In ischemic stroke models, Srgn KO mice showed reduced microglia-mediated neuroinflammation and alleviated ischemic brain injury, indicating that Srgn amplification exacerbates such injury by promoting microglial pro-inflammatory activation via the NF-κB signal pathway and increasing glycolysis in microglia [1]. In TTF-1-negative lung adenocarcinomas, Srgn overexpression was associated with a poor outcome, and in osteoarthritis, Srgn promoted macrophage recruitment through CCL3 regulation [2,3]. In endothelial cells, low shear stress enhanced Srgn expression via the PKA/CREB-dependent signaling pathway, and it may be involved in atherosclerotic plaque formation [4]. In breast cancer, Srgn overexpression was linked to chemoresistance, and in nasopharyngeal carcinoma, STAT3 regulated Srgn to promote tumor growth and metastasis [5,6]. In colorectal cancer, Srgn promoted metastasis as a downstream target of HIF-1α, and in triple-negative breast cancer, it formed a regulatory loop with TGFβ2 to confer invasion and metastasis [7,8]. In hepatocellular carcinoma, Srgn overexpression predicted poor prognosis, and in skin cutaneous melanoma, it was associated with patient survival and immune infiltrates [9,10].

In conclusion, Srgn is involved in a wide range of biological processes and disease conditions. The use of Srgn KO mouse models has been crucial in revealing its role in ischemic stroke, multiple types of cancers, osteoarthritis, and atherosclerosis. Understanding Srgn's functions provides insights into disease mechanisms and potential therapeutic targets.

References:

1. Qian, Yi, Yang, Lixuan, Chen, Jian, Chen, Yan, Xu, Yun. 2024. SRGN amplifies microglia-mediated neuroinflammation and exacerbates ischemic brain injury. In Journal of neuroinflammation, 21, 35. doi:10.1186/s12974-024-03026-6. https://pubmed.ncbi.nlm.nih.gov/38287411/

2. Tanaka, Ichidai, Dayde, Delphine, Tai, Mei Chee, Hanash, Samir, Taguchi, Ayumu. . SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. In Journal of the National Cancer Institute, 114, 290-301. doi:10.1093/jnci/djab183. https://pubmed.ncbi.nlm.nih.gov/34524427/

3. Zhang, Yi, Li, Zihua, Chen, Cheng, Li, Bing, Yang, Yunfeng. 2024. SRGN promotes macrophage recruitment through CCL3 in osteoarthritis. In Connective tissue research, 65, 330-342. doi:10.1080/03008207.2024.2380313. https://pubmed.ncbi.nlm.nih.gov/39067006/

4. Ma, Qinfeng, Gu, Wei, Li, Tianhan, Qiu, Juhui, Wang, Guixue. 2020. SRGN, a new identified shear-stress-responsive gene in endothelial cells. In Molecular and cellular biochemistry, 474, 15-26. doi:10.1007/s11010-020-03830-7. https://pubmed.ncbi.nlm.nih.gov/32712749/

5. Zhang, Zhijie, Qiu, Ni, Yin, Jiang, Liu, Jinbao, Zheng, Guopei. 2020. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression. In Theranostics, 10, 4290-4307. doi:10.7150/thno.41008. https://pubmed.ncbi.nlm.nih.gov/32292495/

6. Wang, Yong-Li, Ren, Dan, Lu, Jin-Long, Liu, Fei, Qu, Shen-Hong. 2022. STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis. In Laboratory investigation; a journal of technical methods and pathology, 102, 919-934. doi:10.1038/s41374-022-00733-7. https://pubmed.ncbi.nlm.nih.gov/35562411/

7. Xu, Yang, Xu, Jie, Yang, Yanfang, Li, Xubin, Zhao, Weipeng. 2018. SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1α. In Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 48, 2429-2440. doi:10.1159/000492657. https://pubmed.ncbi.nlm.nih.gov/30121667/

8. Zhang, Z, Deng, Y, Zheng, G, Gu, Y, He, Z. 2017. SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer. In Oncogenesis, 6, e360. doi:10.1038/oncsis.2017.53. https://pubmed.ncbi.nlm.nih.gov/28692037/

9. He, Lu, Zhou, Xinke, Qu, Chen, Zhang, Qiong, Hong, Jian. 2013. Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients. In Medical oncology (Northwood, London, England), 30, 707. doi:10.1007/s12032-013-0707-4. https://pubmed.ncbi.nlm.nih.gov/23996242/

10. Wang, Xiaofang, Xiong, Hui, Liang, Daning, Li, Xiqing, Zhang, Kun. 2020. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients. In BMC cancer, 20, 378. doi:10.1186/s12885-020-06849-7. https://pubmed.ncbi.nlm.nih.gov/32370744/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest